• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Four Clinical Research Innovators Create Consortium in Massachusetts

Four Clinical Research Innovators Create Consortium in Massachusetts

June 24, 2008
CenterWatch Staff

Four organizations involved in clinical research have joined together to create the Clinical Research Consortium of Massachusetts (CRCM),  a cooperative enterprise that supports knowledge and technology transfer between Massachusetts and other international regions interested in building clinical research centers of excellence. The group’s first work is with the Lombardia region of Italy.

The consortium's members include Tufts Medical Center's Institute for Clinical Research and Health Policy Studies, eclinical company Phase Forward, clinical trials enrollment management company BBK Worldwide, and life sciences consulting firm Court Square Group.

The Massachusetts Office of International Trade and Investment picked these four organizations to help it compete with similar groups from California and North Carolina.

The consortium has already completed its initial work with Lombardia with the submission of its report to the Lombardia  Ministry of Health, outlining a multi-year plan to enhance this region's clinical research and life sciences infrastructure. The Lombardia Ministry of Health indicated it was prepared to move to the next stage of the multi-year project.

According to the consortium, Italy currently has only about 2% of the multi-billion dollar European market for clinical trials, due, in part, to a perception that studies are difficult to conduct there.

"Establishing a regional center of excellence not only will dispel this misperception, but also make giant strides in enhancing drug development and getting new treatments to market sooner by improving access to a very sophisticated and resource-rich region," said Bonnie Brescia, founding principal of BBK Worldwide.

Lombardia is only the first of many such initiatives planned by the consortium. The CRCM joined Governor Patrick at the recent BIO conference in San Diego. Currently, the consortium is in talks with government and life sciences leaders in three countries in South America, and two others in Europe.

At the Drug Information Association’s 44th annual meeting in Boston Tuesday, Paul Bleicher, founder and chairman of Phase Forward, said among the countries the consortium has already been approached by are Brazil and Chile. Robert Weiler, president and chief executive officer of Phase Forward, said the biopharmaceutical companies are increasingly conducting complex clinical trials involving thousands of patients at multiple locations around the world.

“Working together with our consortium partners, we can create a framework that combines our technology solutions with efficient clinical research practices to enable regions such as Lombardia to run clinical trials more quickly and safely," Weiler said.

Harry Selker, M.D., MSPH, executive director for the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, said developing an outstanding infrastructure to facilitate the highest quality clinical research is good for the biomedical research enterprise and patients.

"The Clinical Research Consortium of Massachusetts will enable Tufts Medical Center clinicians and researchers to form partnerships with their counterparts in Italy and, we hope, elsewhere in the world, to share research best practices in addressing the many health problems faced by patients and the public," said Selker.

Keith Parent, CEO of Court Square Group, said that with increasing globalization of clinical trials, sponsors are looking for a single entity to support with the myriad tasks involved in clinical research. “Our consortium provides the full range of expertise they will need. Lombardia has the basic infrastructure needed to participate in clinical trials management, but they want to elevate their game to a world-class level. We're going to help them do that," Parent said.

Daniel O'Connell, Massachusetts’ Secretary of Housing and Economic Development, said the success of the CRCM means job creation for Massachusetts.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing